XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
EQUITY AND MEZZANINE EQUITY (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Schedule of Conversions of Stock Centerspace redeemed Units in exchange for common shares in connection with Unitholders exercising their exchange rights during the three months ended March 31, 2023 and 2022 as detailed in the table below.
(in thousands)
Three Months Ended March 31,Number of UnitsNet Book Basis
2023$(697)
202210 $(388)
Pursuant to the exercise of exchange rights, the Company redeemed Units for cash during the three months ended March 31, 2023 and 2022 as detailed in the table below.
(in thousands, except per Unit data)
Three Months Ended March 31,Number of UnitsAggregate CostAverage Price Per Unit
2023— $— $— 
202231 $2,903 $93.14 
(in thousands)
Number of Series ENumber ofTotal
Three Months Ended March 31,Preferred Units RedeemedCommon Shares IssuedValue
202313 16 $935 
Schedule of Sale of Common Shares The table below provides details on the sale of common shares during the three months ended March 31, 2023 and 2022 under the 2021 ATM Program. As of March 31, 2023, common shares having an aggregate offering price of up to $126.6 million remained available under the 2021 ATM Program.
(in thousands, except per share amounts)
Three Months Ended March 31,Number of Common Shares
Net Consideration(1)
Average Net Price Per Share
2023— $— $— 
2022321 $31,732 $98.89 
(1)Total consideration is net of $338,000 in commissions and issuance costs during the three months ended March 31, 2022.
Schedule of Repurchased Shares The table below provides details on the shares repurchased during the three months ended March 31, 2023. As of March 31, 2023, the Company had $19.9 million remaining authorized for purchase under this program. Refer to Note 12 for repurchases made subsequent to March 31, 2023.
(in thousands, except per share amounts)
Three Months Ended March 31,Number of Common Shares
Aggregate Cost(1)
Average Price Per Share(1)
202319.464 $1,022 $52.51 
(1)Amount includes commissions.